GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 12 filers reported holding GEMPHIRE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $10,614,000 | +56.5% | 1,041,635 | 0.0% | 0.78% | +55.4% |
| Q1 2018 | $6,781,000 | +6.6% | 1,041,635 | +30.2% | 0.50% | -24.2% |
| Q4 2017 | $6,360,000 | -15.8% | 800,000 | 0.0% | 0.67% | -50.0% |
| Q3 2017 | $7,552,000 | -38.5% | 800,000 | -16.0% | 1.33% | -34.5% |
| Q2 2017 | $12,282,000 | +22.8% | 952,798 | 0.0% | 2.04% | +40.1% |
| Q1 2017 | $10,004,000 | +41.8% | 952,798 | +5.9% | 1.45% | +52.8% |
| Q4 2016 | $7,056,000 | -28.2% | 900,000 | 0.0% | 0.95% | -12.3% |
| Q3 2016 | $9,828,000 | – | 900,000 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|